We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Short-course of oral miltefosine for treatment of visceral leishmaniasis.
- Authors
Sundar, S; Makharia, A; More, D K; Agrawal, G; Voss, A; Fischer, C; Bachmann, P; Murray, H W
- Abstract
A total of 54 Indian patients with visceral leishmaniasis were treated with oral miltefosine, 50 mg given twice daily, for 14 days (18 patients; group A), 21 days (18; group B), or 28 days (18; group C). Cure was achieved in 89% of group A, 100% of group B, and 100% of group C. Adverse reactions were self-limited and primarily mild. The 21-day miltefosine regimen combines high-level efficacy, convenient dosing, and a relatively short duration.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Vol 31, Issue 4, p1110
- ISSN
1058-4838
- Publication type
Journal Article
- DOI
10.1086/318122